Investor Relations :: Sigyn Therapeutics, Inc. (SIGY)

Latest News

Jan 25, 2022

Sigyn Therapeutics to Present at the Bullseye Small Cap Virtual Investor Conference

View Press Release

Jan 5, 2022

Sigyn Therapeutics Announces Presentation at Today’s Emerging Growth Conference

Jan 4, 2022

Sigyn Therapeutics CEO Note: 2021 Milestone Achievements / 2022 Clinical Progression / Images of Sigyn Therapy in Action

View All News

Force Wealth Webinar Video

View Presentation

Bullseye Small Cap Virtual Investor Conference

View Event Add to Calendar View All

Q3 2021

Quarter Ended Sep 30, 2021

10-Q

PDF HTML

XBRL

ZIP XLS HTML

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2020

Company Overview

Sigyn Therapeutics is a development-stage therapeutic technology company headquartered in San Diego, California USA. Our focus is directed toward a significant unmet need in global health; the treatment of life-threatening inflammatory conditions that are precipitated by Cytokine Storm Syndrome and not addressed with an approved therapy. Our mission is to save lives.

View Management Team View Board of Directors

Investor Contact Information

Company

Sigyn Therapeutics, Inc.
2468 Historic Decatur Rd.
Suite 140
San Diego, CA 92106
T: 619.353.0800